Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes - PubMed (original) (raw)
. 2014 Dec;63(12):4369-77.
doi: 10.2337/db14-0318. Epub 2014 Jul 21.
Robert A Scott 2, Charles C White 3, Weihua Zhang 4, Elizabeth Speliotes 5, Patricia B Munroe 6, Georg B Ehret 7, Joshua C Bis 8, Caroline S Fox 9, Mark Walker 10, Ingrid B Borecki 11, Joshua W Knowles 12, Laura Yerges-Armstrong 13, Claes Ohlsson 14, John R B Perry 2, John C Chambers 4, Jaspal S Kooner 15, Nora Franceschini 16, Claudia Langenberg 17, Marie-France Hivert 18, Zari Dastani 19, J Brent Richards 20, Robert K Semple 21, Timothy M Frayling 22
Affiliations
- PMID: 25048195
- PMCID: PMC4392920
- DOI: 10.2337/db14-0318
Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes
Hanieh Yaghootkar et al. Diabetes. 2014 Dec.
Abstract
The mechanisms that predispose to hypertension, coronary artery disease (CAD), and type 2 diabetes (T2D) in individuals of normal weight are poorly understood. In contrast, in monogenic primary lipodystrophy-a reduction in subcutaneous adipose tissue-it is clear that it is adipose dysfunction that causes severe insulin resistance (IR), hypertension, CAD, and T2D. We aimed to test the hypothesis that common alleles associated with IR also influence the wider clinical and biochemical profile of monogenic IR. We selected 19 common genetic variants associated with fasting insulin-based measures of IR. We used hierarchical clustering and results from genome-wide association studies of eight nondisease outcomes of monogenic IR to group these variants. We analyzed genetic risk scores against disease outcomes, including 12,171 T2D cases, 40,365 CAD cases, and 69,828 individuals with blood pressure measurements. Hierarchical clustering identified 11 variants associated with a metabolic profile consistent with a common, subtle form of lipodystrophy. A genetic risk score consisting of these 11 IR risk alleles was associated with higher triglycerides (β = 0.018; P = 4 × 10(-29)), lower HDL cholesterol (β = -0.020; P = 7 × 10(-37)), greater hepatic steatosis (β = 0.021; P = 3 × 10(-4)), higher alanine transaminase (β = 0.002; P = 3 × 10(-5)), lower sex-hormone-binding globulin (β = -0.010; P = 9 × 10(-13)), and lower adiponectin (β = -0.015; P = 2 × 10(-26)). The same risk alleles were associated with lower BMI (per-allele β = -0.008; P = 7 × 10(-8)) and increased visceral-to-subcutaneous adipose tissue ratio (β = -0.015; P = 6 × 10(-7)). Individuals carrying ≥17 fasting insulin-raising alleles (5.5% population) were slimmer (0.30 kg/m(2)) but at increased risk of T2D (odds ratio [OR] 1.46; per-allele P = 5 × 10(-13)), CAD (OR 1.12; per-allele P = 1 × 10(-5)), and increased blood pressure (systolic and diastolic blood pressure of 1.21 mmHg [per-allele P = 2 × 10(-5)] and 0.67 mmHg [per-allele P = 2 × 10(-4)], respectively) compared with individuals carrying ≤9 risk alleles (5.5% population). Our results provide genetic evidence for a link between the three diseases of the "metabolic syndrome" and point to reduced subcutaneous adiposity as a central mechanism.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Figures
Figure 1
Cluster analysis of fasting insulin variants using eight traits known to be nondisease metabolic traits of monogenic IR, including those representing dyslipidemia (HDL and triglyceride), adiposity (BMI and visceral-to-subcutaneous adipose tissue ratio), fatty liver (CT-measured hepatic steatosis and the liver enzyme ALT), and adiponectin and SHBG levels. The dendrogram (A) shows that 11 variants and 5 variants are grouped in two significant clusters (the approximate unbiased values = 96% [P = 0.04] and 98% [P = 0.02], respectively). The heatmap (B) shows this cluster is consistent with monogenic lipodystrophic IR; the stronger the green color, the stronger the effect of the insulin-raising allele with reduced trait levels; the stronger the pink color, the stronger the effect of the insulin-raising allele with higher trait levels. VATSAT, visceral-to-subcutaneous adipose tissue ratio; NAFLD, nonalcoholic fatty liver disease.
Figure 2
Forest plots of the effect of the 11 “lipodystrophy-like” variants on six metabolic disease outcomes. The _x_-axis is the effect size per fasting insulin–increasing alleles on each trait. The dashed line is the null effect. For cIMT, actual effects ranged from −0.003 to 0.003 but here are shown rounded to two decimal places. FE, fixed effect.
Comment in
Similar articles
- Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease.
Yaghootkar H, Lotta LA, Tyrrell J, Smit RA, Jones SE, Donnelly L, Beaumont R, Campbell A, Tuke MA, Hayward C, Ruth KS, Padmanabhan S, Jukema JW, Palmer CC, Hattersley A, Freathy RM, Langenberg C, Wareham NJ, Wood AR, Murray A, Weedon MN, Sattar N, Pearson E, Scott RA, Frayling TM. Yaghootkar H, et al. Diabetes. 2016 Aug;65(8):2448-60. doi: 10.2337/db15-1671. Epub 2016 Apr 26. Diabetes. 2016. PMID: 27207519 Free PMC article. - The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.
Sharma R, Prudente S, Andreozzi F, Powers C, Mannino G, Bacci S, Gervino EV, Hauser TH, Succurro E, Mercuri L, Goheen EH, Shah H, Trischitta V, Sesti G, Doria A. Sharma R, et al. Atherosclerosis. 2011 May;216(1):157-60. doi: 10.1016/j.atherosclerosis.2011.01.022. Epub 2011 Jan 26. Atherosclerosis. 2011. PMID: 21353221 Free PMC article. - Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases.
Adeva-Andany MM, Domínguez-Montero A, Adeva-Contreras L, Fernández-Fernández C, Carneiro-Freire N, González-Lucán M. Adeva-Andany MM, et al. Curr Diabetes Rev. 2024;20(5):e160823219824. doi: 10.2174/1573399820666230816111624. Curr Diabetes Rev. 2024. PMID: 37587805 Review. - Visceral adiposity and inflammatory bowel disease.
Rowan CR, McManus J, Boland K, O'Toole A. Rowan CR, et al. Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
- Unsupervised clustering identified clinically relevant metabolic syndrome endotypes in UK and Taiwan Biobanks.
Lim AMW, Lim EU, Chen PL, Fann CSJ. Lim AMW, et al. iScience. 2024 Apr 25;27(7):109815. doi: 10.1016/j.isci.2024.109815. eCollection 2024 Jul 19. iScience. 2024. PMID: 39040048 Free PMC article. - Etiologies underlying subtypes of long-standing type 2 diabetes.
Bayoumi R, Farooqi M, Alawadi F, Hassanein M, Osama A, Mukhopadhyay D, Abdul F, Sulaiman F, Dsouza S, Mulla F, Ahmed F, AlSharhan M, Khamis A. Bayoumi R, et al. PLoS One. 2024 May 28;19(5):e0304036. doi: 10.1371/journal.pone.0304036. eCollection 2024. PLoS One. 2024. PMID: 38805513 Free PMC article. - Genetic Subtypes of Prediabetes, Healthy Lifestyle, and Risk of Type 2 Diabetes.
Li Y, Chen GC, Moon JY, Arthur R, Sotres-Alvarez D, Daviglus ML, Pirzada A, Mattei J, Perreira KM, Rotter JI, Taylor KD, Chen YI, Wassertheil-Smoller S, Wang T, Rohan TE, Kaufman JD, Kaplan R, Qi Q. Li Y, et al. Diabetes. 2024 Jul 1;73(7):1178-1187. doi: 10.2337/db23-0699. Diabetes. 2024. PMID: 38602922 - Association of anthropometric measures with all-cause and cause-specific mortality in US adults: revisiting the obesity paradox.
Li S, Fu Z, Zhang W. Li S, et al. BMC Public Health. 2024 Apr 1;24(1):929. doi: 10.1186/s12889-024-18418-9. BMC Public Health. 2024. PMID: 38556859 Free PMC article. - Genetic Evidence for Distinct Biological Mechanisms That Link Adiposity to Type 2 Diabetes: Toward Precision Medicine.
Abraham A, Cule M, Thanaj M, Basty N, Hashemloo MA, Sorokin EP, Whitcher B, Burgess S, Bell JD, Sattar N, Thomas EL, Yaghootkar H. Abraham A, et al. Diabetes. 2024 Jun 1;73(6):1012-1025. doi: 10.2337/db23-1005. Diabetes. 2024. PMID: 38530928 Free PMC article.
References
- Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699–713 - PubMed
- Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981;34:1617–1621 - PubMed
- Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997;13:65; discussion 64, 66 - PubMed
- Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S. Genetic syndromes of severe insulin resistance. Endocr Rev 2011;32:498–514 - PubMed
Publication types
MeSH terms
Grants and funding
- G0600717/MRC_/Medical Research Council/United Kingdom
- G0500070/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom
- 098498/WT_/Wellcome Trust/United Kingdom
- 100574/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous